High-flow Nasal Cannula Market Analysis

Application (Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease, Acute Heart failure)

The global high-flow nasal cannula market is segmented and analyzed for demand and supply by application into acute respiratory failure, chronic obstructive pulmonary disease (COPD), acute heart failure, and others. Among these segments, the COPD segment is estimated to garner the largest market share as per the market analysis. COPD is a common pulmonary disease that affects the lungs of the patient. Furthermore, the increasing number of COPD cases is owing to the growing occupational inhalation of chemicals or dust. In addition, long-term exposure to tobacco smoke, indoor air pollution from allergens including animal fur, plant pollen, cooking smoke from cow dung or wood, the presence of respiratory infections, and any genetic deficiency are estimated to cause COPD. Across the world, over 3.23 million people died from COPD in 2019, as per the World Health Organization. The treatment with the high flow oxygen via nasal cannula helps to reduce respiratory rate and supports COPD patients with acute hypercapnic respiratory illness. It improves gas exchange in the blood to purify deoxygenated blood. This increase in demand for high flow nasal cannula application in COPD patients is anticipated to surge the segment’s growth in the market.

End-user (Hospitals & Clinics, Ambulatory Care Centers, Long-Term Care Centers)

The global high-flow nasal cannula market is also segmented and analyzed for demand and supply by end-user into hospitals and clinics, ambulatory care centers, long-term care centers, and others. Out of these, the hospitals & clinics segment is estimated to gain the largest market share by the end of 2037 on the back of the requirement for high flow nasal cannulas in hospitals and clinics, which is based on usage for a predetermined number of patients. Moreover, the number of hospitals and surgeries is growing, thus increasing the usage of the nasal cannula in the hospital is further predicted to boost the segment’s growth in the market. Further, approximately 40 to 50 million major surgeries are performed in the USA every year, and about 20 million in Europe, out of 310 million surgeries across the world.  

Our in-depth analysis of the global market includes the following segments: